SCHEMBL7830825

SCHEMBL7830825

CC(C)(CO)CN1CCN(c2ccccc2OCC(F)(F)F)CC1

nearest known ligand 0.62

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 11/20 0.62
ADRA1B P35368 11/20 0.62
ADRA1D P25100 10/20 0.62
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
DRD2 P14416 2/20 0.44
DRD3 P35462 2/20 0.44
DRD4 P21917 1/20 0.44
CACNA1G O43497 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7832834 0.88 ADRA1A (0.62) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL8875425 0.83 DRD2 (0.59) ADRA1AADRA1BADRA1DDRD2DRD3
SCHEMBL7833743 0.83 ADRA1A (0.57) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
Hydrochloric Acid SCHEMBL8980652 0.82 DRD2 (0.58) ADRA1AADRA1BADRA1DDRD2DRD3
SCHEMBL9028727 0.80 ADRA1A (0.60) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL24712880 0.79 DRD2 (0.59) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL7961982 0.76 L3MBTL1 (0.51) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL24712881 0.76 ADRA1A (0.49) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL7835709 0.75 ADRA1A (0.60) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL6771682 0.75 ADRA1A (0.60) ADRA1AADRA1BADRA1DCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed